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The HIV-1 nucleocapsid is formed during protease (PR)-directed viral maturation, and is transformed into pre-integration
complexes following reverse transcription in the cytoplasm of the infected cell. Here, we report a detailed transmission
electron microscopy analysis of the impact of HIV-1 PR and reverse transcriptase (RT) on nucleocapsid plasticity, using in vitro
reconstitutions. After binding to nucleic acids, NCp15, a proteolytic intermediate of nucleocapsid protein (NC), was processed
at its C-terminus by PR, yielding premature NC (NCp9) followed by mature NC (NCp7), through the consecutive removal of p6
and p1. This allowed NC co-aggregation with its single-stranded nucleic-acid substrate. Examination of these co-aggregates for
the ability of RT to catalyse reverse transcription showed an effective synthesis of double-stranded DNA that, remarkably,
escaped from the aggregates more efficiently with NCp7 than with NCp9. These data offer a compelling explanation for results
from previous virological studies that focused on i) Gag processing leading to nucleocapsid condensation, and ii) the
disappearance of NCp7 from the HIV-1 pre-integration complexes. We propose that HIV-1 PR and RT, by controlling the
nucleocapsid architecture during the steps of condensation and dismantling, engage in a successive nucleoprotein-
remodelling process that spatiotemporally coordinates the pre-integration steps of HIV-1. Finally we suggest that
nucleoprotein remodelling mechanisms are common features developed by mobile genetic elements to ensure successful
replication.
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INTRODUCTION
The human immunodeficiency virus type I (HIV-1) encodes three
enzymes: protease (PR), reverse transcriptase (RT) and integrase
(IN). These facilitate the transfer of genetic information from the
HIV-1 genome to the nuclear chromatin of the infected cell. The
homodimeric PR drives the viral maturation process, by the
sequential cleavage of the viral Gag and Gag-Pol precursors [1].
Within the maturing capsid, this process results in the collection of
RT, IN, Vpr and the nucleocapsid, a condensed ribonucleoprotein
complex predominantly comprised of viral RNA coated with
mature nucleocapsid protein (NCp7) [2,3]. Subsequently, within
the confines of the cytoplasm of the infected cell, the heterodimeric
RT catalyses by a sophisticated process the conversion of the RNA
genome into double-stranded DNA (see Animation S1, S2 for an
animated and detailed model of reverse transcription). Finally, IN
(presumably in a tetrameric form [4]) catalyses the concerted
insertion of the two viral DNA ends into the cell’s chromosomal
DNA, allowing the viral DNA or provirus to behave as a cellular
genetic unit.
A unique intracellular pathway involving actin, microtubules
and nuclear pores results in the reverse transcribed HIV-1
genome, which is incorporated into a pre-integration complex
(PIC) that is actively transported into the nuclei of non-dividing
cells [5]. The molecular events that define this route remain to be
clarified. However, this process requires a progressive remodelling
of the viral nucleoprotein architecture. Three critical steps can be
delineated at this level: i) the formation of a condensed RNA-
associated nucleocapsid within the mature capsid [2]; ii) capsid
uncoating [6] and iii) the conversion to a PIC [7]. The related
molecular mechanisms require clarification, and also raise
questions regarding the plasticity of the nucleocapsid during
HIV-1 maturation and reverse transcription.
The HIV-1 nucleocapsid architecture remains poorly defined.
Within mature HIV-1 cores, viral RNA and NCp7 are located
within a condensed ribonucleoprotein complex that also contains
other viral (RT, IN, Vpr, Nef [8]) and cellular components, one of
which is tRNA
Lys3 [9]. NCp7 (55 aa.) is a basic and flexible
peptide, with a critical N-terminal basic domain and two highly
structured and conserved zinc-finger domains separated by
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been observed with NCp7 or NCp9 (the ultimate NCp7
precursor), tRNA
Lys3 [11], RNA [12], as well as DNA [13].
These in vitro co-aggregation properties and their modulation have
been proposed to relate directly to the nucleocapsid architecture
and its plasticity [14]. The aggregates form at the micromolar level
with an NCp:occluded-site stoichiometric ratio of 1:1 [15], a value
close to that observed in virions. Spherical particles containing
hundreds of nucleic acid molecules are observed via transmission
electron microscopy (TEM) to condense and co-aggregate with
thousands of NCp molecules in a complex and dense nucleo-
protein framework [12,14]. Both the basic residues and the zinc-
finger structures of NCp7 are required for a potent effect, while
some NCp7-NCp7 protein contacts directed by nucleic acid
binding are also suspected to be involved within these complexes
[14]. In addition, recent findings [16] demonstrated that NCp7
can bridge between non-contiguous regions of nucleic acid
oligomers, which could account for part of NCp79s aggregative
properties. Interestingly, with magnesium-containing buffers that
facilitate efficient RT activity, co-aggregation is strongly reduced
with double-stranded DNA (dsDNA). This effect is observed with
the mature NCp (NCp7), but not its precursor NCp9 [14]. On the
other hand, NCp15 is deficient in aggregating both single-stranded
DNA (ssDNA) and dsDNA, resulting in DNA coating similar to
prototypical single-stranded binding (SSB) proteins [14,17].
During viral maturation, nucleocapsid condensation and stabili-
zation of dimeric viral RNA require the complete processing of NC
[3,18,19]. Physical cleavage of the capsid (CAp24) and nucleocapsid
(NCp7) proteins from their Gag precursor (MA-CA-p2-NC-p1-p6)
occurs via the primary proteolytic cleavage p2-NC, catalysed by PR,
which leads to NC-p1-p6 (NCp15) [2]. p6 removal from NCp15
results in a transient accumulation of NCp9 (NCp7-p1) followed by
liberation of NCp7 and p1 at the last proteolysis step. The
corresponding PR cleavage sites are considered as secondary and
tertiary cleavage site classes, although RNA strongly activates the
processing of NCp15-to-NCp7 in vitro [1,20]. Moreover, mutations
within both PR-cleavage sites, especially the p1-p6 site, favour
resistance against certain protease inhibitors [21,22], highlighting
that NCp15 processing is essential for viral infectivity.
Reverse transcription complexes (RTCs) evolve from within the
nucleocapsid [23]. As a nucleic acid chaperone protein, NCp7
efficiently assists RT in defined critical events [24] (described in
the Animation S1/S2) such as tRNA
Lys3-directed initiation, the
two obligate strand transfers and central DNA flap termination.
Stability of the newly synthesized HIV-1 DNA within the
cytoplasm of infected cells also requires the presence of functional
NCp7, as viral DNA instability has been shown in HIV-1 mutants
with altered N-terminal or zinc finger domains [25]. In contrast,
NCp7 as well as CAp24 appear predominantly to dissociate from
the full-length linear viral dsDNA extracted from infected cells
within purified RTCs/PICs [7,26,27]. The apparent loss of NCp7
in contrast to the efficient retention of IN and Vpr (viral protein R)
within RTCs and PICs suggests that nucleocapsid disassembly and
PIC assembly are directly interconnected during the reverse
transcription process, while capsid uncoating is also critical for the
generation of an active PIC [6].
A previous study, imaging uranyl-stained nucleoprotein com-
plexes with TEM in annular darkfield mode, showed a selective
preference for NCp7 to co-aggregate with RNA and ssDNA [14].
Taking this into account, we address the architectural changes in
the property of HIV-1 NCp complexed with DNA in the context
of PR and RT activity. The C-terminal cleavage of NCp15 by PR
is identified as the essential step that liberates NCp7 for HIV-1
nucleocapsid condensation. Furthermore, the later double-strand-
ed DNA synthesis by RT appears to be the key step for HIV-1
nucleocapsid protein removal.
RESULTS
NCp15 processing by PR requires single-stranded
nucleic acids to generate NCp7, a reaction that
results in nucleoprotein aggregation
In vitro processing of NCp15 (1 mM) by PR (Figure 1) was studied by
examining the effect of several nucleic acids (ssDNA, G4-DNA,
RNA and dsDNA) in order to address the positive effect on
proteolysis, already shown for RNA [18,20]. Using three PR
concentrationsresulting ina NCp15-to-PRmolar ratioof 20,10and
5 respectively, we found that activation of NCp15 proteolysis in the
presence of nucleic acids effectively depended on their nature. With
dsDNA a very weak stimulation was observed, whereas in the
absence of nucleic acids PR was not active in processing NCp15
under our assay conditions. With ssDNA or RNA the digestion
profiles were much more prominent, and clearly showed that NCp9
was an obligate intermediary. G4-DNA was the most efficient
cofactor in promoting the C-terminal processing of NCp15. With its
four short single-stranded 39 tails linked to six stacked G-quartets
[28], this small DNA molecule has a high affinity binding site for
NCp7 and NCp9 [29]. Thus strongly bound NCp15 species appear
to be the best substrates for complete processing.
The affinity of NCp15 for G4-DNA (10 nM) was examined and
compared with NCp7 in a gel shift assay (Figure 2 A–B). NCp7
formed three species with G4-DNA with the first complex showing
an apparent Kd near the nM range. NCp15 formed only one
detectable complex with a six-fold weaker affinity. NCp15 was also
unable to co-aggregate with ssDNA, unlike NCp7, as shown by
Figure 1. Proteolysis of NCp15 by PR. (A) Sequential and ordered
proteolysis of the HIV-1 NC domain. Digestion of the Gag polyprotein
by PR leads to the mature NCp7 via the NCp15 and NCp9 intermediate
forms [1]. (B) Proteolysis of NCp15 (1 mM) at 30uC and pH 6.6 for 2 h.
The products shown were generated using three concentrations of
recombinant PR (50, 100 and 200 nM) and incubated in the presence of
a circular ssDNA (3,352 nt, 1.25 nM), a G4-DNA (250 nM), a 415-mer RNA
fragment corresponding to the HIV-1 leader region (20 nM) or a 3,352
dsDNA plasmid (1 nM). Controls: p6, NCp9 and NCp7 are shown in the
three far left lanes, whereas products of NCp15 incubation with two
concentrations of PR (50 and 200 nM) in the absence of nucleic acid are
shown to their right.
doi:10.1371/journal.pone.0000669.g001
Control of HIV-1 Nucleocapsid.
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ssDNA like a SSB protein, spreading the DNA on the carbon
film [14]. In contrast, NCp7 strongly co-aggregated with RNA
and ssDNA (TEM, Figure 2D and [14]). Thus interactions
achieved with NCp7 for both the co-aggregation with ssDNA and
the multiple binding with G4-DNA were not possible with NCp15.
Examination of NCp9 in both assays showed that its behaviour
was similar to NCp7 but with a stronger aggregative activity
[14,29], suggesting that p6 inhibits the aggregative properties of
the NC domain within NCp15.
We next followed the aggregation of the ssDNA that occurs
after processing of NCp15 by PR with TEM visualization
(Figure 2F–H). PR-cleavage of NCp15 was indeed able to
overcome the p6-mediated inhibition during the course of
ssDNA-activated proteolysis. At 15 min., an intermediary step
could be visualized via NCp15 conversion to NCp9 and NCp7
species with a limited number of aggregated ssDNA surrounded by
some NCp15-coated ssDNA (Figure 2 F,G). At 40 min., pro-
totypical NCp7- or NCp9-ssDNA co-aggregates were visible
(Figure 2H) under conditions where a mixture of NCp9 and
Figure 2. Differences in DNA binding between NCp15 and NCp7 and the effect of NCp15 proteolysis. (A,B) EMSA using G4-DNA (5 nM) and
increasing amounts of NCp7 or NCp15. Complexes were formed for 15 min. at 37uC before electrophoresis. Note that in the case of NCp15 there is
only one shifted G4-DNA species (A), whereas quantification of the DNA bound fraction as a function of the total NCp concentration (B) shows a 6-
fold drop in affinity for G4-DNA with NCp15 (solid line) compared to NCp7 (dashed line). (C,D,E) TEM visualization of ssDNA (5 nM) without protein (C)
or with saturating amounts (3.4 mM) of NCp7 (D) or NCp15 (E). (F,G,H) TEM visualization of NCp15 proteolysis in the presence of ssDNA after 15 min.
(F and G) and after 40 min. (H) incubation with saturating amounts of NCp bound to ssDNA and a NCp15-to-PR ratio of 30 corresponding to
[NCp15]=3.4 mM, [PR]=100 nM and [ssDNA]=5 nM. The nascent aggregates revealed in (F) are shown with a higher magnification in (G). Scale bars
in each panel correspond to 150 nm.
doi:10.1371/journal.pone.0000669.g002
Control of HIV-1 Nucleocapsid.
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nucleocapsid condensation within the virion.
From ssDNA-NCp7 co-aggregates, dsDNA extrudes
and escapes during HIV-1 RT-directed DNA
synthesis, whereas NCp7 remains bound to the
central DNA flap
The efficiency of reverse transcription within NCp7–ssDNA
aggregates was addressed using an in vitro assay of DNA synthesis
with a circular recombinant ssDNA template encompassing the
minus DNA strand of the HIV-1 cPPT/CTS locus. Adding NCp7
to the assay improved the 99 nt-long strand displacement synthesis
required at the end of the reaction to generate the HIV-1 central
DNA flap [30]. DNA synthesis along the ssDNA template was not
critically affected when saturating amounts of NCp7 (1 NCp7 per 5
nucleotides) were added with increasing amounts of RT (from
6 nM to 500 nM), as shown after an electrophoresis of the
deproteinized DNA products (Figure 3A). A more detailed
examination suggested that adding NCp7 apparently allowed
a slightly more processive elongation for the lowest RT
concentration. Using RT in large excess, some degraded dsDNA
products were observed, due to some contaminating nuclease(s).
Under these conditions (5 mM magnesium and 50 mM sodium in
the absence of RT), NCp7 is known to co-aggregate strongly with
ssDNA, but very poorly with dsDNA [14]. The behaviour of the
DNA circles during the course of DNA synthesis was examined by
sedimentation and electrophoresis (Figure. 3B). We fixed the RT
concentration at an intermediate level (50 nM with 6 nM of
primed DNA) sufficient to catalyse an almost complete DNA
synthesis within 30 min., with or without NCp7. Electrophoresis
revealed that in the presence of NCp7, DNA molecules were fully
aggregated during the course of the reaction without significantly
affecting DNA polymerisation, whereas a significant portion of
final DNA products could be recovered as soluble circles.
Progression of DNA synthesis in the presence of NCp7 was
therefore visualized directly with TEM after incubation for 2, 20
and 40 min. (Figure 4 A,B,C respectively). The corresponding
micrographs provide convincing evidence that elegantly depicts
the reduction in aggregation during the DNA synthesis. At 2 min.,
dsDNA still comprised a very minor portion of the total nucleic
acids and TEM revealed that all DNA circles were still highly
aggregated in globular particles (Figure 4A), with a similar
morphology compared to the NCp7-ssDNA in the absence of
RT (Figure 2D). Once dsDNA was formed it was released from the
aggregates. At 20 min., dsDNA represented roughly one half of
the DNA circles. The aggregates were partially relaxed and
extended. The disaggregated dsDNA was visible at the periphery
as well as between the residual aggregates (Figure 4B). At 40 min.,
reduced networks with only small compact centres, as well as
individual molecules were observed (Figure 4C). The dsDNA
circles that separated from the networks contained a residual
electron-dense aggregate that corresponded to central DNA flaps
bound by NCp7 (see also [14]). Indeed, the addition of 0.4 M
NaCl to the samples with 10 min. of incubation at 70uC prior to
depositing on grids revealed the flap. The residual globular
networks of NCp7 were disrupted, but a small piece of stretched
DNA extended from the circles. This surprising finding suggested
that the NCp7 network bound to the DNA flap was rearranged
during the treatment in a way that allowed ssDNA to spread like
a canonical SSB protein (Figure 4D). Moreover, in accord with
our previous study [30], most of the DNA products contained
a complete central DNA flap (Figure 4E). Their DraIII-AlwNI
digestion generated a discrete band shift indicative of the longer
linear fragment (1800 bp), containing the flap structure, in
contrast to the same fragment obtained after digestion of the
corresponding dsDNA plasmid (control without a DNA flap) or of
RT-generated dsDNA without NCp7 (heterogeneous flap and
broader distribution of products).
NCp-ssDNA co-aggregation followed by nascent
dsDNA extrusion characterizes the wild-type HIV-1
NCp7-RT pair
In order to better understand the critical NCp determinants
involved in ssDNA aggregation and/or in dsDNA extrusion,
several NCp forms were compared in RT assays and examined
after centrifugation or direct TEM visualization of DNA products
(Figure S1). The corresponding results are commented in the
Dataset S1, from which it can be concluded that the N-terminal
Figure 3. Comparison of DNA synthesis by RT in the absence and presence of NCp7. (A) The progression of DNA synthesis is shown with or
without NCp7 for a reaction time of 30 min. as a function of RT concentration. (B) The reaction is shown as a function of time with or without NCp7
for a fixed concentration of RT. The DNA products (B) have been sedimented before electrophoresis. Lower (L) and upper (U) half-volumes collected
after sedimentation are indicated underneath. Concentrations of ssDNA and NCp were, respectively, 5 nM, 3.4 mM (A and B) and RT was 50 nM (B).
DNA and NCp7 were premixed for 4 min. at 37uC, following incubation with RT for 2 min. before addition of dNTPs (100 mM each) to start the
reaction.
doi:10.1371/journal.pone.0000669.g003
Control of HIV-1 Nucleocapsid.
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aggregation of ssDNA followed by controlled extrusion of dsDNA.
Extension of the C-terminus of NCp7 (by the addition of p1, i.e.
NCp9) appeared not to affect aggregation, but limited the
apparent release of both dsDNA and NCp. Indeed, significantly
stronger retention of dsDNA with ssDNA-NCp9 co-aggregates in
Mg
2+-containing buffer has already been shown [14], whereas in
force-induced DNA denaturation experiments, NCp7 has been
proposed to have an increased mobility when bound to DNA
compared to NCp9 [17].
As HIV-1 RT appeared not to be active in the presence of
Moloney-murine leukaemia virus (Mo-MuLV) NCp10, we tested
whether Mo-MuLV RT was active under these conditions (Figure
S1 and Dataset S1). Mixing Mo-MuLV RT with Mo-MuLV NCp
or HIV-1 NCp in the assay led to efficient DNA synthesis.
Therefore, Mo-MuLV NCp10 does not complement HIV-1 RT,
whereas HIV-1 NCp7 does so for Mo-MuLV RT.
DISCUSSION
The present results illustrate how a nucleoprotein architecture that
mimics a retroviral nucleocapsid can be directly modulated by two
retroviral enzymes: i) a protease, PR, that preferentially cleaves its
NCp substrate once bound to nucleic acids, thus changing its
binding properties to a strongly aggregative mode; and ii) a DNA
polymerase, RT, which translocates along its single-stranded
template, changing it to a more weakly aggregative double-
stranded nucleic acid form while displacing the initially bound
NCp7 proteins. With such remarkable remodelling properties,
demonstrated here for the first time, it is clear that HIV-1 PR and
RT are engaged in controlling the nucleoprotein architecture of
the HIV-1 genetic material between viral maturation and cellular
infection. Below, we discuss the biological impact of these findings
in the context of the HIV-1 replication cycle.
Examining the proteolytic process whereby NCp7 is produced
from RNA-bound NCp15, several conclusions can be drawn from
our data, confirming the earlier study of Sheng et al. [18,20]. A
simplified model simulating the nucleocapsid maturation from an
immature capsid is shown in Figure 5. NC domains in the Gag
precursor (from ,1500 copies [31] to 5000 [32]) cover the inner
surface of the immature capsid (Figure 5A). These domains
capture RNA and contribute to its shape with a weak RNA-
chaperone activity [17]. The first event in Gag processing is PR
cleavage between p2 and NCp15, which allows an overall physical
separation of the NCp-RNA complex from the surrounding capsid
[2] (Figure 5B). Once NCp15 is produced, two populations of
NCp15 can be distinguished: one bound to RNA, fully covering it,
and the other free or bound to non-RNA components. The
NCp15 subpopulation that is not bound to RNA is not processed
by PR (as shown in Figure 1A), unless other ligands stimulate PR
activity. This subpopulation should be excluded from the final
nucleocapsid architecture simultaneously with the fractional
exclusion proposed for CAp24 from the conical network during
capsid maturation [32,33]. In contrast, the RNA-bound NCp15
pool is subjected to a new round of proteolysis that leads to NCp9,
and then to an ultimate round that forms NCp7 [20] (Figure 5
C,D). Moreover, compensatory mutations are shown to emerge at
the p1- p6 cleavage site to support drug-resistant PR [21], or
directly to confer resistance against a new PR inhibitor [22]. p6
removal allows co-aggregation of NCp9 with nucleic acids
(Figure 2, [14]). The subsequent p1 removal produced NCp7
already aggregated with the condensed RNA in a 1:1 stoichio-
metric ratio. Therefore NCp7-NCp7 contacts (i.e. weak interac-
Figure 4. Extrusion of dsDNA produced by RT from ssDNA-NCp7 co-aggregates. Progression of DNA synthesis analyzed by TEM after 2 min. (A),
10 min. (B) and 40 min. (C) from reactions with ssDNA (5 nM), RT (50 nM) and NCp7 (3.4 mM). Disaggregation after 10 min. (B) appeared both at the
periphery and within the aggregates. A few individual molecules were visible close to the aggregate after 40 min. (C). (D) A typical DNA product
visualized by TEM after 40 min. of DNA synthesis with subsequent incubation for 15 min. at 70uC in the presence of 0.4 M NaCl. (E) Band shift analysis
of DNA flap synthesis within the dsDNA produced by RT after 40 min. at 37uC with 50 nM RT, with or without 3.4 mM NCp7. An excess of DraI and
AlwnI enzymes that digest this dsDNA into two fragments (1800 and 1500 bp) was added. The DraI-AlwnI digestion products of the plasmid DNA are
shown as a control on the left. When the HIV-1 central DNA flap is fully synthesized (i. e. with NCp7), the 1800 bp fragment is shifted to a slower
migrating band. Magnification is identical for panels A,B,C. The scale bars correspond to 250 nm.
doi:10.1371/journal.pone.0000669.g004
Control of HIV-1 Nucleocapsid.
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regions [16] must be engaged in the nucleocapsid architecture.
Contacts induced between RNA-bound NCp7 by p6/p1 removal
are also suggested by the difference in binding to the G4-DNA
substrate: multiple and discrete for NCp7, but single and weaker
for NCp15. Conversely, NCp9 binding to the G4-DNA substrate
easily shifts to an aggregated state, unlike NCp7 [29], and it is
proposed to interact with RNA more stably than NCp7 [17]. This
can be correlated with easier RT-directed removal of NCp7 after
conversion of the genome to dsDNA (compare Figures 4 and S1).
These data emphasize the C-terminal proteolysis of NCp,
catalysed by PR, as a finely optimized mechanism that controls
the conformation and reactivity of NC domains to drive the
formation of nucleocapsid. A first step of condensation is followed
by a second step that enhances plasticity. Such a mechanism can
be linked with the stabilization of the RNA dimer [34] and,
perhaps, the conical assembly of the mature capsid [35,36].
With regard to interactions with the nucleocapsid, Vpr, RT and
IN are depicted in our model as bulky partners (Figure 5), based
on the proposed stoichiometry within the virion [32]. Vpr is
retained within the capsid due to its affinity for Gag-associated p6
[37] and/or NC domains [38]. p6 domains directly favour the
retention of the Gag-Pol protein within the immature capsid [39].
Most of PR, RT and IN proteins are presumed to be already in
their mature form when PR digests NCp15 molecules. The series
of events that drives auto-activation of PR and maturation of RT
and IN also follows a sequential and ordered pathway, beginning
with the p2-NC cleavage [40]. The precise locations of RT and IN
within the maturing capsid still need to be defined; their presence
is important for HIV-1 RNA maturation [41]. Moreover, IN
interacts with RT and promotes reverse transcription [42]. Our
data involving RT (Figure 4) suggests that this enzyme alone can
easily diffuse into the nucleocapsid as it is readily accessible to
primers in NCp7-ssDNA co-aggregates. Of interest is that HIV-1
NCp7 cannot be substituted in our assay with Mo-MuLV NCp10,
which fully inhibits HIV-1 RT. Encapsidation of other cellular and
viral proteins may also be controlled by the nucleocapsid
architecture. Some cellular proteins, such as actin [43], APO-
BEC3G [44], and tRNA
Lys3-synthetase [9], bind to the HIV-1 NC
domains. Among the viral auxiliary proteins, i) Vif (viral infectivity
factor) is poorly detectable in the HIV-1 mature core, even though
it binds cooperatively to the HIV-1 leader RNA [45], ii) Nef
(negative factor) is known to be sequestered into the viral core [46],
iii) a PR-cleaved form of Tat (transactivator of transcription)
Figure 5. Hypothetical model of HIV-1 nucleocapsid assembly controlled by PR-directed NCp15 proteolysis. The HIV-1 immature (A) and mature
(E) capsid are depicted, focusing on the nucleoprotein region. This model was inspired from L. Henderson’s (NCI-Frederick) illustration, taking into
account the ratios of Gag, Gag-pol, NCp, PR, RT, IN and Vpr. (B) Gag cleavage between p2 and NCp15 by PR resulting in RNA-bound NCp15 removal
from the capsid domains. (C) and (D) digestion of RNA-bound NCp15 yielding NCp9 (C), followed by NCp7 (D) which yields to an overall aggregation/
condensation of the nucleocapsid that leads to (E).
doi:10.1371/journal.pone.0000669.g005
Control of HIV-1 Nucleocapsid.
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sequestered [47]. The mode of sequestration or exclusion within
the HIV-1 core for each of these components can now be
examined in the context of NCp7-RNA or NCp7-ssDNA co-
aggregation. The three possibilities are: internalisation within the
nucleocapsid: retention at its periphery, or exclusion during the
condensation process.
Examining DNA synthesis catalysed by RT in the presence of
NCp7, the disruption of ssDNA-NCp aggregates is observed as
ssDNA is converted into dsDNA. In Figure 6 another model is
presented to show the remodelling activity of HIV-1 RT. With
regard to DNA-directed DNA polymerisation (i.e. enzyme trans-
location along the ssDNA template to synthesize the dsDNA), the
HIV-1 RT activity is almost as efficient with ssDNA aggregated
with NCp7 as in an aqueous solution of naked ssDNA. Apart from
DNA synthesis per se, the presence of magnesium, necessary for RT
function, results in a strong and selective reduction of NCp-
dsDNA aggregation due to a lower binding efficiency [14]. Under
such conditions, the progressive disruption of the interactions
involved in the initial NCp7-ssDNA co-aggregates demonstrates
that NCp7 molecules bound to nucleic acids are progressively
displaced by HIV-1 RT during its tracking along the minus strand
DNA template, while re-binding of NCp7 to the dsDNA product is
severely impaired (Figure 4). Hence HIV-1 RT acts here as
a molecular motor that dismantles the overall nucleocapsid
architecture, in a similar way to the dismantling of Rec-like
nucleofilaments by certain DNA helicases [48]. In the case of RT,
the energy is provided by dNTP hydrolysis, whereas the formation
of dsDNA in the presence of magnesium robustly reduces NCp7
reassociation. This in vitro property strongly suggests that the
formation of pre-integration complexes is a direct consequence of
reverse transcription during the infection process. A complete
separation of fully synthesized dsDNA from the residual aggregates
is quite slow and may be assisted by other destabilizing factors.
Finally, some residual NCp7 copies should, at the end of our assay,
remain aggregated to the last single-stranded segment of the
circular DNA, the central DNA flap, which is efficiently produced
by RT with the assistance of NCp7 (Figure 4 D,E and [30]). These
NCp7 molecules may contribute to the protection of the DNA flap
structure and/or assist in its binding to yet to be identified cellular
proteins.
Until now authentic changes of the nucleocapsid architecture
have not been demonstrated during the process of reverse
transcription, although NCp7 has been shown to assist RT in
several critical steps [24]. Therefore, we speculate that two
different modes might be involved in the disruption of this
architecture (see Animation S1/S2). One consists of a progressive
dismantling associated with RT translocation throughout the
process. The other requires the formation of dsDNA, i.e. the plus
strand DNA synthesis, taking into account that NCp7 should easily
rebind to RNA-DNA heteroduplexes and to ssDNA, the transient
species that appear during the process. Indeed, in vitro assays
mimicking the minus strand synthesis have shown that NCp7 and
the RNA-DNA/ssDNA products are aggregated [49,50]. A subtle
question arises as to what happens with the RNA fragments that
are generated through the action of the RT-associated RNAseH
during viral DNA synthesis [51,52]. One would assume that they
constitute an additional dispersing force for NCp7, causing its
dissociation from RTCs, which may have occurred to a large
extent at the time of plus strand DNA synthesis. RTC or PIC
complexes isolated from infected cells contain IN and Vpr, but
very little NCp7 [27]. For this reason we propose that NCp
removal favours IN and Vpr sequestration on dsDNA (Figure 6B).
Moreover, this dismantling may also favour the recruitment of
cellular dsDNA binding proteins, with IN and Vpr possibly
participating in the selection of suitable proteins. Such sequestra-
tions and recruitments should be oriented and controlled during
the plus strand DNA synthesis by binary initiation (39 ppt and
cppt) and termination (LTR duplication and central flap synthesis)
[53]. Strands displaced during the course of termination should be
the last portions to retain NCp7, especially the central DNA flap,
while the HIV-1 LTR double-stranded DNA ends should promote
active IN assemblies (Figure 6B).
Alongside this switch from nucleocapsid to PIC, there is another
important point regarding architectural plasticity that concerns the
relationships between reverse transcription, the nucleocapsid and
the surrounding capsid assemblies. RTCs/PICs extracted from
cells have lost not only NCp7, but also most of their CAp24 [26].
Yet the mechanism, as well as the spatiotemporal coordination of
capsid uncoating are still not clearly understood [54]. It has been
Figure 6. Hypothetical model for HIV-1 nucleocapsid dismantling
controlled by RT directed dsDNA synthesis. (A) translocation of RT on
a minus DNA template coated with NCp7. RT displaces NCp7 during this
translocation reaction while converting ssDNA into dsDNA, which does
n o ta l l o wN C p 7t or e - a s s o c i a t ei na na g g r e g a t i v em o d e .T h e
dismantling force is driven by dNTP hydrolysis that allows continuous
RT translocation. Magnesium is critical as it weakens dsDNA-binding by
NCp7. (B) macroscopic consequence of the NCp7 dismantling activity of
RT. A reverse transcription complex is depicted from a perspective of
the nucleocapsid architecture used in figure 5. Once reverse
transcription is finished, resulting in dsDNA, the aggregative nucleic
acid binding mode of NCp7 is drastically reduced, facilitating the
binding of Vpr and IN (as well as other available cellular partners) and
thus generating a PIC (represented here in a simplified way according
to Nermut et al.[27]).
doi:10.1371/journal.pone.0000669.g006
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transcription and transition to PIC formation [6]. Binding of the
Trim-cyclophilin restriction system to capsid, as well as the CAp24
mutations that affect capsid stability, effectively invoke defects in
reverse transcription, nuclear import or integration [55,56].
Therefore we propose that reverse transcription and disruption
of the nucleocapsid might be coupled to capsid uncoating in
a process that requires further exploration. Such changes may also
be linked to the trafficking of the HIV-1 genome during cellular
infection [5,57], in order to expose key components to the
required cellular partners, i.e., actin, microtubule-associated
molecular motors and nuclear import machinery [58]. Further in
vitro reconstitution experiments using direct visualization will help
to understand better the related molecular mechanisms that
control the plasticity and the movement of the HIV-1 nucleopro-
tein architecture during viral maturation as well as in the early
steps of cellular infection.
Finally, we believe that this remodelling strategy of nucleopro-
tein architecture is a characteristic that may be employed by most,
if not all mobile genetic elements to optimize their capability for
propagation within host cells and thus to ensure their survival.
Virally encoded proteases, RNA/DNA-polymerases and RNA/
DNA-helicases should be carefully examined for their possible
contribution to this strategy.
METHODS
Protein, DNA and reagents
Recombinant HIV-1 PR and RT were prepared as described
[59,60]. HIV-1 PR was titrated fluorometrically [61]. RT
concentration was determined using an extinction coefficient at
280 nm of 260,450 M
21cm
21. Recombinant HIV-1 wild-type
NCp(1-55) (i.e. NCp7) and NCp15 (based on sequences from
GenBank, accession number AF324493) were expressed and
purified as described [62–64]. The p6 peptide was provided by S.
Bouaziz (Universite ´ Paris 5). Mo-MuLV NCp10 was expressed and
purified essentially as described above for HIV-1 NCp7. Alterna-
tively, synthetic Mo-MuLV NCp10 was obtained as a generous gift
from J. L. Darlix (ENS, Lyon). AlwNI, DraI and Mo-MuLV RT
enzymes were purchased from New England Biolabs (Ipswich,
MA). The circular 3,352 nt single-stranded DNA, that contains the
HIV-Bru cPPT-CTS sequence, as well as its plasmid counterpart,
were prepared as described [30]. The 17 mer-oligonucleotide
ODN 17 (DNA, 59-TTGGGGGGTACAGTGCA) used for the
G4-DNA and as a primer for reverse transcription was purchased
from Eurogentec (Seraing, Belgium). DNA concentrations were
measured in a Genequant microspectrophotometer (APBiotech).
The 1-415 RNA fragment corresponding to the HIV-1 leader
region was a generous gift from J. L. Darlix (ENS, Lyon). All other
reagents used in this study were of the highest grade available and
were purchased from established manufacturers.
NCp15 proteolysis
NCp15 (2 mM) was first incubated with nucleic-acids (ssDNA,
2.5 nM; G4-DNA, 500 nM; RNA, 40 nM; dsDNA, 2 nM) for
10 min. at 37uCi n1 0ml of a PR buffer (0.02% [w/v] KCl,
0.012% KH2PO4, 0.091% Na2HPO4, pH 6.6) containing
100 mM NaCl. Next, PR equilibrated in its reaction buffer was
added for 2 h at 30uC. The reaction was stopped by the addition
of an equal volume of SDS-PAGE loading buffer. Reaction
products were heated to 100uC prior to Tris-Tricine SDS-PAGE
on an 8–16% gradient gel followed by silver staining (Invitrogen).
Purified NCp7, NCp15 and p6 proteins were used as migration
controls.
G4-DNA Electrophoretic Mobility Shift Assay (EMSA)
33P-labelled parallel G-quadruplex DNA was prepared by in-
terstrand association of the ODN 17 (with 200 mM KCl at 40uC
for 30 h) prior to radiolabelling as described [28]. The standard
G4-DNA binding assay (10 ml) was performed as described [29].
The fraction of NCp-bound DNA was determined as the ratio of
bound DNA (all the shifted bands for NCp7) to the total number
of counts in each lane. The apparent equilibrium dissociation
constant (Kdapp) was estimated via the protein concentration
necessary for half maximal DNA binding.
DNA synthesis
The 3,352-nt circular ssDNA template was hybridized to ODN
17. The polymerase reaction was carried out in the RT buffer
(50 mM Tris-acetate pH 7.8, 50 mM sodium acetate, 6 mM
magnesium acetate and 0.5 mM DTT) at 37uC. For analysis by
agarose gel electrophoresis, DNA products were heated to 70uC
for 10 min. in the presence of 1% (w/v) SDS and 20 mM EDTA,
(see [30] for more details). Samples of DNA produced in the
presence of NCp7 were also centrifuged for 10 min at 90006g at
4uC and the upper half volume of each sample was separated very
carefully before heat treatment and electrophoresis.
Transmission Electron Microscopy
EM observations were performed with a positive staining
procedure as described previously [30,65,66]. 5 ml-aliquots of
NCp/DNA complexes (DNA concentration of 2.5–5 nM) were
diluted 5-fold in the reaction buffer without DTT, deposited onto
the EM grid, rinsed with an aqueous uranyl acetate solution (2%
w/v) and dried. This deposition procedure rapidly adsorbed DNA
molecules onto the carbon film with no significant loss of three-
dimensional information [67]. To avoid precipitation of phosphate
buffer with uranyl acetate, NCp15 proteolysis by PR was
performed in 50 mM sodium-acetate (pH 6.0) and 4 mM
magnesium-acetate. Aliquots were then diluted 5-fold in 50 mM
HEPES pH 7.0 before their deposition onto the grid. Negative
films of NCp-DNA complexes were captured for final magnifica-
tions of up to 85,0006, and then converted to digital images with
a high-resolution scanner (LaCie BlueScan).
SUPPORTING INFORMATION
Animation S1 An animated model of HIV-1 reverse transcrip-
tion. In order to better understand the overall process of HIV
reverse transcription, an animated model is available here for
downloading. Animation S1 is a MOV file for viewing with Apple
Quicktime and Animation S2 is a SWF file for viewing with the
Flash plugin of Microsoft Internet Explorer or Mozilla Firefox web
browsers. Note that with the MOV file (S2) the space bar is
available to pause and to start the animation. This animation is
derived from the classical model of reverse transcription [A.
Telesnitsky and S. P. Goff, Reverse transcriptase and the
generation of retroviral DNA, in Retrovirus, J. M. Coffin, S. H.
Hughes and H. E. Varmus Eds, (1997) CSHL Press]. For clarity,
this animation represents an idealized process with a figure-of-
eight-shaped nucleic-acid template. Attention has been focused on
the following points: the three primers (tRNALys3, 39ppt and cppt)
are oversized for clarity; the two RNA ends (RU5 and U3R) are in
close proximity throughout reverse transcription, in order to show
a continuous process at the time of the strand transfers; the RT-
associated RNAseH is shown with a high activity for digestion of
the RNA following minus strand DNA elongation. The two
polypurine tracts are presented as the two exclusive primers for
Control of HIV-1 Nucleocapsid.
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are proposed to be displaced by the two translocating RT molecules
during minus strand DNA elongation. The central DNA flap is
viewed as a fluctuating structure, the function of which still needs to
be elucidated. The presentation of the timing for plus strand DNA
termination in combination with the central flap synthesis and LTR
duplication seemsthe mostrepresentative tothe authors.This model
does not exclude alternative pathways, especially considering the
dimeric nature of the initial RNA template.
Found at: doi:10.1371/journal.pone.0000669.s001 (0.13 MB
MOV)
Animation S2 See Legend of Animation S1.
Found at: doi:10.1371/journal.pone.0000669.s002 (0.13 MB
SWF)
Figure S1 Differences in DNA synthesis depending on the origin
of NCp and RT. (A) Comparison of the effects of HIV-1 NCp7,
NCp9 and NCp12-53 vs. Mo-MuLV NCp10 (3 mM) on DNA
synthesis catalysed by HIV-1 RT (50 nM) and analysed after 10
and 40 min. incubation. Samples were micro-sedimented before
electrophoresis to evaluate the level of DNA aggregation. (B) TEM
of DNA synthesis after 40 min. of incubation with HIV-1 RT and
NCp9. (C) Comparison of DNA synthesis by HIV-1 RT (200 nM)
and Mo-MuLV RT (200 U) after 20 and 60 min. in the absence
or presence of HIV-1 NCp7 or Mo-MuLV NCp10 (3 mM)
respectively, without micro-sedimentation of the samples. (D)
TEM visualization of DNA synthesis with Mo-MuLV RT and
NCp10. The scale bars correspond to 250 nm.
Found at: doi:10.1371/journal.pone.0000669.s003 (5.60 MB TIF)
Dataset S1 Comments for Figure S1
Found at: doi:10.1371/journal.pone.0000669.s004 (0.02 MB
DOC)
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